Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Meng Zhuo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100989244, A5102481705. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2016: 3 papers · 2017: 3 papers · 2018: 2 papers · 2019: 1 paper · 2020: 2 papers

Papers 11

  1. Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer. Co-author DOI 10.1186/s12935-020-1135-0↗
  2. Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma. First author DOI 10.20892/j.issn.2095-3941.2019.0427↗
  3. JQ1 effectively inhibits vasculogenic mimicry of pancreatic ductal adenocarcinoma cells via the ERK1/2-MMP-2/9 signaling pathway both in vitro and in vivo. Co-author PMID 30899402↗
  4. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of po… Co-author DOI 10.1186/s12885-018-4954-9↗
  5. Synergistic effects of the combination of 5-Aza‑CdR and suberoylanilide hydroxamic acid on the anticancer property of pancreatic cancer. First author DOI 10.3892/or.2017.6059↗
  6. Elevated COX-2 Expression Promotes Angiogenesis Through EGFR/p38-MAPK/Sp1-Dependent Signalling in Pancreatic Cancer. Co-author DOI 10.1038/s41598-017-00288-4↗
  7. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancrea… Co-author DOI 10.18632/oncotarget.14069↗
  8. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray. Co-author DOI 10.18632/oncotarget.16633↗
  9. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13277-015-4741-z↗
  10. Aberrant expression of nuclear HDAC3 and cytoplasmic CDH1 predict a poor prognosis for patients with pancreatic cancer. Co-author DOI 10.18632/oncotarget.7663↗
  11. Sp1 and COX2 expression is positively correlated with a poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.8593↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ting Han · 11 shared papers, 2016–2020 · strength 0.96
  2. Feng Jiao · 11 shared papers, 2016–2020 · strength 0.96
  3. Jiujie Cui · 6 shared papers, 2017–2020 · strength 0.60
  4. Hai Xia Hu · 7 shared papers, 2016–2019 · strength 0.54
  5. Liwei Wang · 6 shared papers, 2016–2017 · strength 0.41
  6. Liwei Wang · 3 shared papers, 2018–2020 · strength 0.33
  7. Liwei Wang · 2 shared papers, 2018–2020 · strength 0.22
  8. Lei Wang · 3 shared papers, 2016–2017 · strength 0.20
  9. Leilei Wu · 2 shared papers, 2017 · strength 0.14
  10. Junjie Hang · 2 shared papers, 2016 · strength 0.13
  11. Yiyi Liang · 1 shared paper, 2020 · strength 0.13
  12. Yu Wang · 1 shared paper, 2017 · strength 0.08
  13. Lixia Wu · 1 shared paper, 2017 · strength 0.07
  14. Haiyan Yang · 1 shared paper, 2016 · strength 0.06
  15. Yangyang Zhou · 1 shared paper, 2016 · strength 0.06
  16. Junjie Huang · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.